115 related articles for article (PubMed ID: 480194)
1. The influence of endogenous glucagon release on hyperglycemic responses to catecholamines in normal fed and diabetic rats.
Woodson LC; Potter DE
J Pharmacol Exp Ther; 1979 Sep; 210(3):458-64. PubMed ID: 480194
[TBL] [Abstract][Full Text] [Related]
2. Isoproterenol- and epinephrine-induced changes in blood glucose and tissue glycogen levels in normal and diabetic rats: the influence of alteration in endogenous insulin levels and state of nourishment.
Potter DE; Ellis S
J Pharmacol Exp Ther; 1975 May; 193(2):576-84. PubMed ID: 1142106
[TBL] [Abstract][Full Text] [Related]
3. Catecholamine-induced changes in plasma glucose, glucagon and insulin in rabbits: effects of somatostatin.
Potter DE; Barnett JW; Woodson LC
Horm Metab Res; 1978 Sep; 10(5):373-7. PubMed ID: 361531
[TBL] [Abstract][Full Text] [Related]
4. Catecholamine-induced hyperglycemia in dogs: independence from alterations in pancreatic hormone release.
Woodson LC; Bee DE; Potter DE
Horm Metab Res; 1980 Sep; 12(9):434-9. PubMed ID: 6107269
[TBL] [Abstract][Full Text] [Related]
5. Role of glucagon in the hyperglycemic response to catecholamines in fasted baboons.
Woodson LC; Kempen RR; Bee DE; Potter DE
Pharmacology; 1978; 17(4):221-6. PubMed ID: 99754
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of stress induced hyperglucagonemia by administration of glucose in normal and alloxan-diabetic rat.
Klimes I; Jurcovicová J; Németh S; Jezová D; Vigas M
Endocrinol Exp; 1981; 15(2):87-97. PubMed ID: 7021127
[TBL] [Abstract][Full Text] [Related]
7. Effects of recurrent hyperinsulinemia with and without hypoglycemia on counterregulation in diabetic rats.
Inouye K; Shum K; Chan O; Mathoo J; Matthews SG; Vranic M
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1369-79. PubMed ID: 12006368
[TBL] [Abstract][Full Text] [Related]
8. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
[TBL] [Abstract][Full Text] [Related]
9. Glucagon secretion in rats with non-insulin-dependent diabetes: an in vivo and in vitro study.
Giroix MH; Portha B; Kergoat M; Picon L
Diabete Metab; 1984 Jan; 10(1):12-7. PubMed ID: 6724097
[TBL] [Abstract][Full Text] [Related]
10. Isoproterenol-induced insulin release in normal rats and hyperglycemia in alloxan-diabetic rats: a preliminary report.
Potter DE; Wilson LM; Ellis S
Res Commun Chem Pathol Pharmacol; 1974 Apr; 7(4):787-90. PubMed ID: 4828772
[No Abstract] [Full Text] [Related]
11. The effect of experimental insulin deficiency on glucagon secretion.
Müller WA; Faloona GR; Unger RH
J Clin Invest; 1971 Sep; 50(9):1992-9. PubMed ID: 4935445
[TBL] [Abstract][Full Text] [Related]
12. [Studies on anti-hyperglycemic effect and its mechanism of Dendrobium candidum].
Wu HS; Xu JH; Chen LZ; Sun JJ
Zhongguo Zhong Yao Za Zhi; 2004 Feb; 29(2):160-3. PubMed ID: 15719686
[TBL] [Abstract][Full Text] [Related]
13. Increased responses of glucagon and glucose production to hypoglycemia with intraperitoneal versus subcutaneous insulin treatment.
Wan CK; Giacca A; Matsuhisa M; El-Bahrani B; Lam L; Rodgers C; Shi ZQ
Metabolism; 2000 Aug; 49(8):984-9. PubMed ID: 10954014
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
[TBL] [Abstract][Full Text] [Related]
15. Morphine-induced hyperglycemia: role of insulin and glucagon.
Ipp E; Schusdziarra V; Harris V; Unger RH
Endocrinology; 1980 Aug; 107(2):461-3. PubMed ID: 6993188
[TBL] [Abstract][Full Text] [Related]
16. State of metabolic control determines role of epinephrine-glucagon interaction in glucoregulation in diabetes.
Kemmer FW; Lickley HL; Gray DE; Perez G; Vranic M
Am J Physiol; 1982 Jun; 242(6):E428-36. PubMed ID: 6124126
[TBL] [Abstract][Full Text] [Related]
17. Effect of somatostatin and a glucagon-specific analog on glucose homeostasis during arginine infusion.
Lien EL
Metabolism; 1978 Sep; 27(9):1095-100. PubMed ID: 682972
[TBL] [Abstract][Full Text] [Related]
18. Relative contributions of the nervous system and hormones to CNS-mediated hyperglycemia.
Iguchi A; Gotoh M; Matsunaga H; Yatomi A; Honmura A; Yanase M; Sakamoto N
Am J Physiol; 1988 Dec; 255(6 Pt 1):E920-7. PubMed ID: 2904767
[TBL] [Abstract][Full Text] [Related]
19. Superactive somatostatin analog decreases plasma glucose and glucagon levels in diabetic rats.
Karashima T; Schally AV
Peptides; 1988; 9(3):561-5. PubMed ID: 2901737
[TBL] [Abstract][Full Text] [Related]
20. Comparative hyperglycemic responses to norepinephrine salbutamol and glucagon in normal and alloxan-diabetic insulin-controlled rabbits.
Potter DE; Moratinos J; Ellis S
Arch Int Pharmacodyn Ther; 1974 Jun; 209(2):358-68. PubMed ID: 4441174
[No Abstract] [Full Text] [Related]
[Next] [New Search]
